6/21/2024  5:36:05 PM Chg. -0.200 Volume Bid8:51:00 AM Ask8:51:00 AM Market Capitalization Dividend Y. P/E Ratio
23.400EUR -0.85% 0
Turnover: 0.000
23.200Bid Size: 20 23.600Ask Size: 222 280.8 mill.EUR 1.92% 26.29

Business description

PharmaSGP is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals sold over the counter (“OTC”) and other healthcare products. PharmaSGP’s products are sold exclusively through pharmacies. Its products are based on natural active pharmaceutical ingredients with documented efficacy and fewer known side effects than most chemical-based pharmaceuticals. The Company’s core brands cover chronic indications, including pain and other age-related ailments. In Germany, PharmaSGP is the market leader for systemic chemical-free pain remedies with its brand families RUBAXX® for rheumatic pain and RESTAXIL® for neuralgic pain. Furthermore, PharmaSGP has introduced leading products against sexual weakness and vertigo symptoms.

Management board & Supervisory board

Natalie Weigand
Management board
Michael Rudolf
Supervisory board
Dr. Clemens Fischer, Madlena Hohlefelder, Dr. Axel Rebien

Company data

Name: PharmaSGP Holding SE
Address: Lochhamer Schlag 21,D-82166 Gräfelfing
Phone: +49-611-2058-5528
Fax: +49-611-2058-5566
E-mail: info@pharmasgp.com
Internet: https://pharmasgp.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: -
IPO date: 6/19/2020

Investor relations

Name: Claudius Krause
IR phone: +49-611-2058-5535
IR Fax: -
IR e-mail: ir@pharmasgp.com

Company calendar

CW 26 | 6/27/2024 Ex-Dividend
CW 26 | 6/28/2024 Record Date
CW 27 | 7/1/2024 Dividend Payment

Main Shareholders

FUTRUE GmbH / MVH Beteiligungs- und Beratungs-GmbH
Union Investment Privatfonds GmbH
Swedbank Robur Fonder AB